Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Webster Brian Daniel, holds the title of See Remarks at KESTRA MEDICAL TECHNOLOGIES, LTD..
On 2026-11-18, the insider transacted 15,000 shares.The shares were transacted at a weighted average price of $28.46 per share, resulting in a total market-relevant value of $427K.
Webster Brian Daniel (See Remarks) sold $427K of $KMTS
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.